R5- and X4-HIV-1 use differentially the endometrial epithelial cells HEC-1A to ensure their own spread: implication for mechanisms of sexual transmission

Virology. 2007 Feb 5;358(1):55-68. doi: 10.1016/j.virol.2006.07.029. Epub 2006 Aug 24.

Abstract

The mechanism of viral transmission across the mucosal barrier is poorly understood. Using the endometrial epithelium-derived cell line HEC-1A, we found that the cells are capable of sequestering large numbers of HIV-1 particles but are refractory to cell-free viral infection. The removal of heparan sulfate moieties of cell-surface proteoglycans (HSPG) from the apical pole of HEC-1A accounted for at least 60% of both R5- and X4-HIV-1 attachment, showing their important implication in viral attachment. HEC-1A cells also have the capacity to endocytose a weak proportion of the attached virus and pass it along to underlying cells. Fucose, N-acetylglucosamine and mannosylated-residues inhibited the transcytosis of some virus isolates, suggesting that mannose receptors can be implicated on the both R5- and X4-HIV-1 transcytosis. The inhibition of HIV transcytosis by blocking CCR5 mAb suggests the implication of specific interaction between the viral gp120 and sulfated moiety of syndecans during the transcytosis of mostly R5- and X4-HIV-1. At the basolateral pole of HEC-1A, HSPG sequestered X4- and not R5-HIV-1, highlighting the important role of HEC-1A as an X4 virus reservoir. The cell-free virus particles that have transcytosed could infect activated T cells but with a weaker efficiency than virus that had not transcytosed. The specific stimulation of HEC-1A by R5-HIV-1 increased the release of monocytes/chemokines-attracting chemokines (IL-8 and GR0) and proinflammatory cytokines (TNF-beta and IL-1alpha) that enhanced the production of virus by activated T cells. This study suggests that R5 and X4 viruses can differentially use epithelial cells to ensure their own spread.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylglucosamine / pharmacology
  • Anti-HIV Agents / pharmacology
  • CCR5 Receptor Antagonists
  • Cell Line
  • Chemokine CXCL1
  • Chemokines, CXC / biosynthesis
  • Endocytosis / drug effects
  • Endometrium / virology*
  • Epithelial Cells / virology*
  • Female
  • Fucose / pharmacology
  • HIV Core Protein p24 / analysis
  • HIV Infections / transmission
  • HIV Infections / virology
  • HIV-1 / immunology
  • HIV-1 / pathogenicity
  • HIV-1 / physiology*
  • Heparan Sulfate Proteoglycans / physiology
  • Humans
  • Interleukin-1alpha / biosynthesis
  • Interleukin-8 / biosynthesis
  • Lectins, C-Type / physiology
  • Mannose / analogs & derivatives
  • Mannose / pharmacology
  • Mannose Receptor
  • Mannose-Binding Lectins / physiology
  • Receptors, CCR5 / physiology*
  • Receptors, CXCR4 / physiology*
  • Receptors, Cell Surface / physiology
  • Tumor Necrosis Factor-alpha / biosynthesis
  • Virulence
  • Virus Attachment

Substances

  • Anti-HIV Agents
  • CCR5 Receptor Antagonists
  • CXCL1 protein, human
  • Chemokine CXCL1
  • Chemokines, CXC
  • HIV Core Protein p24
  • Heparan Sulfate Proteoglycans
  • Interleukin-1alpha
  • Interleukin-8
  • Lectins, C-Type
  • Mannose Receptor
  • Mannose-Binding Lectins
  • Receptors, CCR5
  • Receptors, CXCR4
  • Receptors, Cell Surface
  • Tumor Necrosis Factor-alpha
  • Fucose
  • Mannose
  • Acetylglucosamine